Developing tests to identify cancer biomarkers
Biomarker Developmental Unit
This study is working on new tests to find early signs of lung and ovarian cancers in patients, which could help catch these diseases sooner and improve how we monitor them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10927280 on NIH RePORTER |
What this research studies
This research focuses on adapting and validating assays for detecting biomarkers related to lung and ovarian cancers. By collaborating with Meso Scale Diagnostics, the team aims to enhance diagnostic methods through the identification of novel serological markers, including autoantibodies and anti-glycosylated protein antibodies. These biomarkers can signal the presence of cancer at very early stages, even before traditional detection methods can identify tumors. Patients may benefit from improved early detection and monitoring of cancer through these innovative assays.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for lung or ovarian cancer, as well as those with unexplained symptoms that may indicate these conditions.
Not a fit: Patients with cancers other than lung or ovarian cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of lung and ovarian cancers, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using serological markers for early cancer detection, indicating that this approach has potential for success.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Stengelin, Martin — Arizona State University-Tempe Campus
- Study coordinator: Stengelin, Martin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.